Yi Hui Wu

Director Ejecutivo en Hangzhou Puyang Investment Management Co., Ltd. .

Fortuna: 72 M $ al 31/05/2024

51 años

15 relaciones

Health Technology

Consumer Services

Distribution Services

Perfil

Yi Hui Wu currently works at Zhejiang Tiansong Medical Instrument Co., Ltd., as Independent Director from 2019, Hangzhou Puyang Investment Management Co., Ltd., as General Manager & Executive Director from 2016, and Medtide, Inc., as Non-Executive Director from 2024.
Mr. Wu also formerly worked at Zhejiang Jindao Technology Co., Ltd., as Director.
Mr. Wu received his graduate degree from Zhejiang University of Finance & Economics.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SUPCON TECHNOLOGY CO., LTD. CLASS A 1.94%	30/09/2023	10 363 914 ( 1.94% )	61 M $	31/05/2024
SERVYOU SOFTWARE GROUP CO. LTD. CLASS A 4.04%	31/12/2023	3 654 327 ( 4.04% )	11 M $	31/05/2024

Cargos activos de Yi Hui Wu

Empresas	Cargo	Inicio
Hangzhou Puyang Investment Management Co., Ltd. Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China.	Director Ejecutivo	13/10/2016
Zhejiang Tiansong Medical Instrument Co., Ltd. Zhejiang Tiansong Medical Instrument Co., Ltd. Medical SpecialtiesHealth Technology Zhejiang Tiansong Medical Instrument Co., Ltd. engages in the research and development, production, and sale of endoscopic minimally invasive medical devices. Its products include abdominal surgery, orthopedic surgery, microsurgery, and gynecological endoscope minimally invasive medical equipment. The company was founded by Tian Song Xu and Tang Zhu Xu on August 28, 1998 and is headquartered in Hangzhou, China.	Director/Miembro de la Junta	16/09/2019
Taide Pharmaceutical (Zhejiang) Co., Ltd. Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China.	Director/Miembro de la Junta	01/01/2022

Todos los cargos activos de Yi Hui Wu

Antiguos cargos conocidos de Yi Hui Wu.

Empresas	Cargo	Fin
ZHEJIANG JINDAO TECHNOLOGY CO., LTD.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Yi Hui Wu.

Formación de Yi Hui Wu.

Zhejiang University of Finance & Economics

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yi Hui Wu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
	Health Technology
ZHEJIANG JINDAO TECHNOLOGY CO., LTD.	Distribution Services

Empresas privadas	2
Hangzhou Puyang Investment Management Co., Ltd. Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China.	Finance
Taide Pharmaceutical (Zhejiang) Co., Ltd. Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China.	Health Technology